Arecor Therapeutics PLC - West Sussex, England-based biopharmaceutical firm - Delays publication of 2023 results, which were due to be published Tuesday next week. Says its auditor, Grant Thornton UK LLP, requires more time to complete procedures. Says it will now announce its results in the week commencing May 13.
Current stock price: 137.84 pence
12-month change: down 49%
By Sophie Rose, Alliance News senior reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Arecor Therape (AREC)